Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

13 Jun 2021

17.57

3.17%

AGM

Lasa Supergenerics Ltd - 540702 - Proceedings Of The Hon'Ble NCLT / Court Convened Meeting (CCM) …

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, as amended, we are submitting herewith the summary of proceedings of the Court Convened Meeting of the Company held on Saturday, June 12, 2021 at 10:30 A.M and commenced at 11:00 am Indian Standard Time ('IST') due to want of quorum, which then concluded at 11:45 am. (Including time allowed for e-voting at the CCM) through Video Conferencing/ Other Audio Visual Means ('VC/OAVM').

pdf

Lasa Supergenerics Ltd.

09 Jun 2021

17.57

3.17%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Attached is the copy of Press Release titled 'LASA launches new product - Oxyclozanide Creating new Capacity as a brown field expansion' issued by the company.

pdf

Lasa Supergenerics Ltd.

04 Jun 2021

17.57

3.17%

Earnings Call for Q4FY21 of Lasa Supergenerics

Conference Call with Lasa Supergenerics Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.

Lasa Supergenerics Ltd.

01 Jun 2021

17.57

3.17%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Attached is the copy of Press Release titled 'LASA SUPERGENERICS ANNOUNCES ROBUST PAT AT 22.80CRS, UP 521% YOY, with Recommendation of Dividend' issued by the company

pdf

Lasa Supergenerics Ltd.

01 Jun 2021

17.57

3.17%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, June 04, 2021 at 02:00 p.m. IST for discussing the Audited financial results of the Company for the quarter and financial year ended March 31, 2021.

pdf

Lasa Supergenerics Ltd.

31 May 2021

17.57

3.17%

Corp. Action

Lasa Supergenerics Ltd - 540702 - Board recommends Final Dividend

BSE India

Lasa Supergenerics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2021, inter alia, has recommendationof the final Dividend of Rs. 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.

pdf

Lasa Supergenerics Ltd.

31 May 2021

17.57

3.17%

Result

Lasa Supergenerics Ltd - 540702 - Results- Financial Year Ended March 31, 2021

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 11:00 am and concluded at 01:30 p.m. inter- alia have considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2021. 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached herewith.

pdf

Lasa Supergenerics Ltd.

31 May 2021

17.57

3.17%

Result

Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. May 31, 2021

BSE India

pdf

Lasa Supergenerics Ltd.

28 May 2021

17.57

3.17%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to SEBI Circular CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed copy of the of Annual Secretarial Compliance Report dated May 27, 2021 issued by Shivam Sharma & Associates, for the financial year 2020-2021.

pdf

Lasa Supergenerics Ltd.

24 May 2021

17.57

3.17%

Company Update

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Notice Of Postponement And Intimation Of …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/05/2021 ,inter alia, to consider and approve To consider and recommend Dividend for the financial year 2020-21 Other agenda items remains same

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%